Agile BioScience

SEC-MALS

Agile BioScience: Unmatched Aggregate Analysis with SEC-MALS

SEC-MALS is a gold-standard technique for characterizing protein services aggregates and determining absolute molecular weight. Agile BioScience offers expert SEC-MALS analysis to ensure the quality and safety of your biopharmaceuticals, supporting your regulatory submissions.

Why SEC-MALS Matters:
  • ​Size & Quantitation of Aggregates: SEC-MALS simultaneously separates protein species based on size and determines their precise molecular weight, enabling accurate quantification of aggregates.
  • Independent of Reference Standards: Provides direct molecular weight determination, unlike traditional SEC that relies on standards.
  • Supports Regulatory Expectations: Delivers the type of robust aggregate characterization data often requested by regulatory authorities.
Our Approach:
  • ​Integrated Analysis: We combine SEC-MALS with complementary techniques (e.g., SDS-PAGE, AUC) for orthogonal confirmation of aggregation.
  • The MALS signals, along with UV absorbance and/or differential refractive index (dRI) signals, are analyzed to quantify the analyte’s physical properties.
  • Data-Driven Guidance: We go beyond data generation, providing insights to aid in troubleshooting aggregation and ensure product quality.
Benefits of Choosing Agile BioScience:
  • ​Confidence in Aggregate Characterization: Obtain accurate and reliable data on aggregation levels.
  • Streamlined Development: Identify and address aggregation issues early, accelerating your timeline
  • Regulatory Success: Our SEC-MALS data supports your product submissions and demonstrates a commitment to quality.
​Contact us to learn how SEC-MALS can empower your biopharmaceutical development.